Based in the United States, Aitia is a startup.
Aitia develops a Gemini Digital Twin platform that uses causal AI and multiomic patient data to create in silico models of human disease biology, aiding pharmaceutical companies in drug discovery and development.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.